Literature DB >> 25651170

Metformin action: concentrations matter.

Ling He1, Fredric E Wondisford2.   

Abstract

Metformin has been used for nearly a century and is now the most widely prescribed oral anti-diabetic agent worldwide. Yet how metformin acts remains only partially understood and controversial. One key reason may be that almost all previous studies were conducted with supra-pharmacological concentrations (doses) of metformin, 10-100 times higher than maximally achievable therapeutic concentrations found in patients with type 2 diabetes mellitus.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25651170     DOI: 10.1016/j.cmet.2015.01.003

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  148 in total

1.  Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.

Authors:  Jessica J Howell; Kristina Hellberg; Marc Turner; George Talbott; Matthew J Kolar; Debbie S Ross; Gerta Hoxhaj; Alan Saghatelian; Reuben J Shaw; Brendan D Manning
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

2.  Direct assessment of renal mitochondrial redox state using hyperpolarized 13 C-acetoacetate.

Authors:  Cornelius von Morze; Michael A Ohliger; Irene Marco-Rius; David M Wilson; Robert R Flavell; David Pearce; Daniel B Vigneron; John Kurhanewicz; Zhen J Wang
Journal:  Magn Reson Med       Date:  2018-01-03       Impact factor: 4.668

Review 3.  Sex disparities matter in cancer development and therapy.

Authors:  Sue Haupt; Franco Caramia; Sabra L Klein; Joshua B Rubin; Ygal Haupt
Journal:  Nat Rev Cancer       Date:  2021-04-20       Impact factor: 60.716

4.  Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes.

Authors:  Adam R Konopka; Raul Ruiz Esponda; Matthew M Robinson; Matthew L Johnson; Rickey E Carter; Michele Schiavon; Claudio Cobelli; Fredric E Wondisford; Ian R Lanza; K Sreekumaran Nair
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

5.  Duodenal energy sensing regulates hepatic glucose output.

Authors:  Brennan K Smith; Gregory R Steinberg
Journal:  Nat Med       Date:  2015-05       Impact factor: 53.440

Review 6.  Metformin as an Anticancer Agent.

Authors:  Ales Vancura; Pengli Bu; Madhura Bhagwat; Joey Zeng; Ivana Vancurova
Journal:  Trends Pharmacol Sci       Date:  2018-08-24       Impact factor: 14.819

7.  Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?

Authors:  Irem Dogan Turacli; Haldun Umudum; Arzu Pampal; Tuba Candar; Lara Kavasoglu; Yaren Sari
Journal:  Mol Biol Rep       Date:  2018-02-03       Impact factor: 2.316

Review 8.  Spatial control of AMPK signaling at subcellular compartments.

Authors:  Anoop Singh Chauhan; Li Zhuang; Boyi Gan
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-02-18       Impact factor: 8.250

Review 9.  Mitochondrial dynamics in exercise physiology.

Authors:  Tomohiro Tanaka; Akiyuki Nishimura; Kazuhiro Nishiyama; Takumi Goto; Takuro Numaga-Tomita; Motohiro Nishida
Journal:  Pflugers Arch       Date:  2019-02-01       Impact factor: 3.657

10.  Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.

Authors:  Jennifer M Johnson; Stephen Y Lai; Paolo Cotzia; David Cognetti; Adam Luginbuhl; Edmund A Pribitkin; Tingting Zhan; Mehri Mollaee; Marina Domingo-Vidal; Yunyun Chen; Barbara Campling; Voichita Bar-Ad; Ruth Birbe; Madalina Tuluc; Ubaldo Martinez Outschoorn; Joseph Curry
Journal:  Semin Oncol       Date:  2015-09-24       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.